HOME >> BIOLOGY >> NEWS
Scientists' cell discovery unearths evolutionary clues

The full family tree of the species known as social amoebas has been plotted for the first time a breakthrough which will provide important clues to the evolution of life on earth.

Researchers, headed by evolutionary biologist Professor Sandie Baldauf, of the University of York, and biochemist Professor Pauline Schaap, of the University of Dundee, have produced the first molecular 'dictionary' of the 100 or so known species of social amoeba.

Using this family tree, they have devised a model system to establish how single cell organisms communicate and interact to create multi-cellular structures in response to changing environmental conditions. Previously, there was almost no molecular data for social amoeba Dictyostelia which are a hugely diverse and ancient group.

Social amoebas are a group of organisms with a genetic diversity that is greater than that of fungi and similar to that of all animals. They offer an excellent experimental system for studying aspects of evolution and communication that are not easy to study in more complex multi-cellular organisms.

The York and Dundee teams have worked with field biologists in Germany, the US and Japan, and their research is published today (Friday 27th October 2006) in the prestigious international journal Science.

The published paper shows for the first time the family tree of all known social amoeba species and the evolution of their multicellular life style.

"This provides a starting point in allowing us to examine what happens at the molecular level as species evolve and mutate," said Professor Schaap, of the Division of Cell and Developmental Biology in the College of Life Sciences at Dundee.

"The availability of a family tree allows us to reconstruct the evolution of the signalling mechanisms that generate multicellularity. It also provides a powerful tool to identify core ancestral processes that regulate the most basic aspects of de
'"/>

Contact: David Garner
dcg501@york.ac.uk
1-904-432-153
University of York
27-Oct-2006


Page: 1 2 3

Related biology news :

1. Scientists pied piper approach may have found Nemo faster
2. Enzyme discovery sheds light on vitamin D
3. New proteomics research promises to revolutionize biomedical discovery
4. MU researchers make discovery in molecular mechanics of phototropism
5. International team to honor 30th anniversary of deep-sea vent discovery in Galpagos
6. Screening approach leads to discovery of gene linked to breast cancer
7. Lucky 13 as new gene discovery offers further hope for childhood blindness
8. Plants that produce more vitamin C may result from UCLA-Dartmouth discovery
9. Biting discovery: MU entomologist finds host of new aquatic insect species in Thailand
10. J&JPRD discovery may lead to new treatments for chronic sensitivity, pain caused by cold
11. Protein enables discovery of quantum effect in photosynthesis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Scientists cell discovery unearths evolutionary clues

(Date:5/7/2015)... , May 7, 2015 ... sensors, FPC1022 and FPC1035, FPC,s smallest touch fingerprint ... are mainly considered for integration on the backside ... smartphone OEMs increased possibilities to integrate touch fingerprint ... size also improves possibilities for module manufacturers to ...
(Date:4/27/2015)... Profile Solutions, Inc. (OTC: PSIQ), a leading ... pleased to announce that Dr Gerry Bedore ... of its scientific advisory board. ... leader in technology-enhanced learning models. He was a co-founder ... studies and books focused on online student success and ...
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. ... Online (FIDO ® ) Alliance tm , an ... FIDO members commit to share technology and collaborate ... that are interoperable, more secure and private, and ... biometric identity verification that protects sensitive user information ...
Breaking Biology News(10 mins):FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
(Date:5/21/2015)... NOVATO, Calif. , May 21, 2015 /PRNewswire-USNewswire/ ... Orrin Hatch (R-UT) and Amy ... Product Extensions Now Accelerating Cures & Treatments, or ... 150 rare disease patient advocacy organizations, this bipartisan ... effective, and affordable medicines to rare disease patients ...
(Date:5/21/2015)... W. R. Grace & Co. ... Worms, Germany has received good manufacturing practice (GMP) ... International Pharmaceutical Excipient Council (IPEC) Foundation. ... SYLOID® FP brand of pharmaceutical grade excipient silica ... Curtis Bay, Maryland (USA) and Sorocaba, Brazil locations. ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... Research and Markets ( http://www.researchandmarkets.com/research/84975r/2015_global ... "2015 Global Survey on Flow Cytometry Adoption Trends" ... primary goal of this research is to analyze ... Key information the survey seeks to collect include ... predominantly used applications for flow cytometers, respondents, most ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2
Cached News: